Cosentyx - An Injectable Drug for Psoriatic Arthritis and Ankylosing Spondylitis

Cosentyx - An Injectable Drug for Psoriatic Arthritis and Ankylosing Spondylitis Approved by the FDA at the beginning of the year, Cosentyx is the first drug to target interleukin-17A. The more treatment options, the better since not all drugs are equally effective for individual patients. READ NOW  READ THESE NEXT What Is a Spon-dyloarthropathy? MORE What Distinguishes Psoriatic Arthrits From Other Types of Arthritis? MORE Stelara Is a Monoclonal Antibody Like Cosentyx But With Different Targets MORE AN ABOUT.COM BRAND You are receiving this newsletter because you subscribed to the Real Life with Arthritis newsletter. If you wish to unsubscribe, please click here 1500 Broadway, 6th Floor, New York, NY, 10036 © 2016 Verywell.com - All rights reserved. Privacy Policy.